Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04293042 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Treatment of BK Virus Infection With CTL Cells in Immunocompromised Transplant Patients

Study acronym: BK-CTLs
StatusRecruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Jan 30, 2027 to Jan 30, 2028
    • Study completion date: Dec 30, 2028 to Jan 30, 2029
    v8
  2. Primary completion date: Jan 30, 2025 to Jan 30, 2027
    • Study completion date: Dec 30, 2025 to Dec 30, 2028
    v7
  3. Site contact updatedv6
  4. Primary completion date: Dec 30, 2023 to Jan 30, 2025
    • Study completion date: Dec 30, 2024 to Dec 30, 2025
    • Site contact updated
    v5
  5. Primary completion date: Dec 30, 2022 to Dec 30, 2023
    • Study completion date: Dec 30, 2023 to Dec 30, 2024
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Re-verified, no change to tracked fieldsv3
  2. Site contact updatedv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a pilot study using cytotoxic T lymphocytes (CTLs) manufactured with the Miltenyi CliniMACS Prodigy Gamma-capture system will be effective in decreasing specific viral load in patients with BK virus viremia and BK virus-associated symptoms post-allogeneic hematopoietic stem cell transplantation (HSCT), renal transplantation, and chemotherapy.
Trial Details
NCT Number NCT04293042
Lead Sponsor Children's Hospital of Philadelphia
Conditions
(from sponsor)		 BK Polyomavirus
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov